Categories
Resources
Your Recalls
Loading...
Get email alerts when new recalls match your interests.
Presence of Foreign Tablets/Capsules
CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
Product contains undeclared FD&C Yellow 5 and FD&C Yellow 6.
CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.
Crystallization
may contain metal pieces